Related Experiment Video
Updated: Apr 20, 2026
An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C
Published on: June 1, 2018
IDH2 mutation-induced histone and DNA hypermethylation is progressively reversed by small-molecule inhibition
Andrew Kernytsky1, Fang Wang1, Erica Hansen1
1Agios Pharmaceuticals, Cambridge, MA.
Abstract:
Mutations of IDH1 and IDH2, which produce the oncometabolite 2-hydroxyglutarate (2HG), have been identified in several tumors, including acute myeloid leukemia. Recent studies have shown that expression of the IDH mutant enzymes results in high levels of 2HG and a block in cellular differentiation that can be reversed with IDH mutant-specific small-molecule inhibitors. To further understand the role of IDH mutations in cancer, we conducted mechanistic studies in the TF-1 IDH2 R140Q erythroleukemia model system and found that IDH2 mutant expression caused both histone and genomic DNA methylation changes that can be reversed when IDH2 mutant activity is inhibited. Specifically, histone hypermethylation is rapidly reversed within days, whereas reversal of DNA hypermethylation proceeds in a progressive manner over the course of weeks. We identified several gene signatures implicated in tumorigenesis of leukemia and lymphoma, indicating a selective modulation of relevant cancer genes by IDH mutations. As methylation of DNA and histones is closely linked to mRNA expression and differentiation, these results indicate that IDH2 mutant inhibition may function as a cancer therapy via histone and DNA demethylation at genes involved in differentiation and tumorigenesis.
Insights
Mutations in IDH1 and IDH2 enzymes create 2-hydroxyglutarate (2HG), blocking cancer cell differentiation. Inhibiting these mutant IDH enzymes reverses this block, offering a potential cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Mutations in isocitrate dehydrogenase (IDH) genes (IDH1 and IDH2) are linked to various cancers, producing the oncometabolite 2-hydroxyglutarate (2HG).
- High 2HG levels from mutant IDH enzymes cause cellular differentiation arrest, a hallmark of certain leukemias.
Purpose of the Study:
- To investigate the role of IDH mutations in cancer development and differentiation.
- To explore the mechanistic effects of IDH2 R140Q mutations in an erythroleukemia model.
- To assess the impact of IDH mutant inhibition on epigenetic modifications and gene expression.
Main Methods:
- Utilized the TF-1 erythroleukemia cell line expressing IDH2 R140Q mutant.
- Analyzed histone and genomic DNA methylation changes in response to IDH2 mutant expression and inhibition.
- Examined gene expression signatures related to tumorigenesis and differentiation.
Main Results:
- IDH2 mutant expression induced significant histone and DNA hypermethylation.
- Inhibition of IDH2 mutant activity rapidly reversed histone hypermethylation within days.
- DNA hypermethylation reversal was progressive, occurring over weeks, and modulated key cancer-related genes.
- Identified gene signatures implicated in leukemia and lymphoma tumorigenesis.
Conclusions:
- IDH mutations contribute to cancer through epigenetic dysregulation (histone and DNA methylation).
- IDH mutant inhibition shows therapeutic potential by reversing aberrant methylation patterns.
- Targeting IDH mutations may restore normal cellular differentiation and combat tumorigenesis in IDH-mutated cancers.
More Related Videos
Related Concept Videos
01:37Epigenetic Regulation
X-chromosome...
01:46Epigenetic Regulation
01:32Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
01:17Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
02:32Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
02:32Histone Modification